按需鼻内皮质类固醇喷雾治疗过敏性鼻炎:系统综述与荟萃分析
本系统综述与荟萃分析纳入8项随机对照试验共882例过敏性鼻炎患者,评估按需鼻内皮质类固醇喷雾(INCS)的疗效。结果显示规律使用INCS在鼻部总症状评分和疾病特异性生活质量上优于按需使用,但按需INCS在鼻部总症状评分上优于按需抗组胺药和安慰剂。三组比较中不良事件风险均无差异。
要点
- 规律使用INCS在鼻部总症状评分和疾病特异性生活质量上优于按需INCS,效应量小。
- 按需INCS在鼻部总症状评分上优于按需抗组胺药和安慰剂,效应量中等。
- 按需INCS与规律INCS在眼部症状、无症状天数、鼻痒和流涕评分上无差异。
核心结论
- 规律使用INCS改善鼻部总症状评分和疾病特异性生活质量优于按需INCS。
- 按需INCS改善鼻部总症状评分优于按需抗组胺药和安慰剂。
- 按需INCS的效应更接近规律INCS而非安慰剂或按需抗组胺药。
研究设计与样本
- 系统检索随机对照试验,比较按需INCS与规律INCS、按需抗组胺药或安慰剂的效果。
- 共纳入8项研究,882例参与者。
- 主要结局为鼻部总症状评分(TNSS)和疾病特异性生活质量(DSQoL)。
主要发现
- 规律使用INCS在TNSS、DSQoL、鼻吸气峰流量、打喷嚏和鼻塞评分上优于按需INCS,效应量小。
- 规律与按需INCS在眼部症状、无症状天数、鼻痒和流涕评分上无差异。
- 按需INCS优于按需抗组胺药和安慰剂,效应量中等。
- 三种比较中,组间不良事件风险均无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As-needed intranasal corticosteroid spray (INCS) is commonly used by patients with allergic rhinitis (AR) who have suboptimal symptom control. This systematic review aimed to assess the effectiveness of as-needed INCS for treating AR. METHODOLOGY: Systematic searches for randomized controlled trials studying the effects of as-needed INCS compared to regular INCS, as-needed antihistamine, or placebo were performed. Primary outcomes were total nasal symptom score (TNSS) and disease-specific quality of life (DSQoL). RESULTS: Eight studies (882 participants) met the criteria. Regular use of INCS showed greater improvements than as-needed INCS in TNSS, DSQoL, nasal peak inspiratory flow, sneezing, and nasal congestion scores with small effect sizes. There were no differences between regular and as-needed INCS usage for ocular symptoms, symptom-free days, nasal itching, and rhinorrhea scores. As-needed INCS was superior to as-needed antihistamine and placebo with medium effect sizes. There were no differences in risk of adverse events between the groups in all three comparisons. CONCLUSIONS: Regular use of INCS improved total nasal symptoms score and DSQoL better than as-needed INCS. However, as-needed INCS improved TNSS better than as-needed antihistamine and placebo. The effects of as-needed INCS were closer to regular INCS usage than to placebo or as-needed AH usage.
引用
- Hoang MP, Chitsuthipakorn W, Seresirikachorn K, et al. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis. Rhinology. 2022. PMID: 35379997. doi:10.4193/Rhin21.355
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。